A device that could potentially allow blind people — even those born without the sense of sight — to see has received the U.S. Food and Drug Administration’s “breakthrough device” designation.
Neuralink, the brain chip company founded by Elon Musk, announced the approval Tuesday. The FDA program is for medical devices that offer more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions.
The designation aims to give […]
FDA gives special designation to Neuralink brain chip designed to allow blind to see – NY1